Comparing two blood-clotting treatments for liver transplant surgery
Treatments studied
Part of Blood & lymphatic, Digestive system, Heart & circulation clinical trials.
This study compares two blood-clotting medicines used during liver transplant surgery. The goal is to see which one works better to control bleeding and keep you safe during the operation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have liver disease and are getting a liver transplant.
- The study will give you one of two treatments that help your blood clot during surgery.
- There are no strict medical exclusions listed, but you should be healthy enough for transplant surgery.
- You must be able to understand and agree to the study's plan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two treatments (prothrombin complex concentrate and fresh frozen plasma) for managing bleeding during heart surgery. It aims to find which approach works better and is safer for patients.
This trial tests whether using a slightly different target on a blood-clotting test (ROTEM) can reduce the need for blood transfusions in people with liver disease who need a procedure. If you have cirrhosis or ACLF with severe clotting problems, this study may help your doctors decide how much blood product to give you before the procedure.
This trial tests whether giving fibrinogen, a protein that helps blood clot, reduces bleeding during liver transplant surgery. It may help patients with certain liver conditions who are at higher risk of bleeding.
This trial studies how doctors manage bleeding before, during, and after liver transplant surgery. The goal is to improve safety and outcomes for people receiving a new liver.
This Phase 4 study looks at how clotting measurements relate to bleeding risk in people with liver cirrhosis who need a planned liver procedure. The study may help doctors understand what coagulation results mean when doing these procedures safely.
This trial uses stored blood samples to see how well different lab tests measure clotting when someone has a factor deficiency (like low levels of clotting proteins) or liver damage. It may help doctors choose the most accurate test for these situations.
Hear when a new Liver Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.